Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Ordinary shares, par value $0.0001 per share
-
Shares outstanding
-
1,385,160,313
-
Total 13F shares
-
54,296,531
-
Share change
-
-619,595
-
Total reported value
-
$14,026,755,839
-
Put/Call ratio
-
355%
-
Price per share
-
$258.39
-
Number of holders
-
234
-
Value change
-
-$183,663,940
-
Number of buys
-
122
-
Number of sells
-
135
Institutional Holders of BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) as of Q4 2020
As of 31 Dec 2020,
BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) was held by
234 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
54,296,531 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, HILLHOUSE CAPITAL ADVISORS, LTD., Capital International Investors, FMR LLC, BAILLIE GIFFORD & CO, PRIMECAP MANAGEMENT CO/CA/, Temasek Holdings (Private) Ltd, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, and BOXER CAPITAL, LLC.
This page lists
234
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.